Ubs Group Ag Lexaria Bioscience Corp. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Ubs Group Ag holds 6,074 shares of LEXX stock, worth $5,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,074

Holding current value

$5,041

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.85 - $1.69 $5,162 - $10,265	6,074 New	6,074 $5,000
Q4 2024 Feb 14, 2025	BUY	$2.01 - $3.3 $233 - $382	116 New	116 $0
Q4 2023 Feb 09, 2024	BUY	$0.92 - $1.69 $4,169 - $7,659	4,532 New	4,532 $5,000
Q2 2023 Aug 11, 2023	SELL	$0.69 - $2.69 $3,132 - $12,212	-4,540 Reduced 97.87%	99 $0
Q1 2023 May 12, 2023	SELL	$2.47 - $3.47 $2,363 - $3,320	-957 Reduced 17.1%	4,639 $12,000
Q4 2022 Feb 08, 2023	SELL	$1.95 - $2.98 $1,563 - $2,389	-802 Reduced 12.54%	5,596 $13,000
Q3 2022 Nov 10, 2022	BUY	$0.74 - $3.28 $1,647 - $7,304	2,227 Added 53.39%	6,398 $16,000
Q2 2022 Aug 10, 2022	BUY	$1.88 - $4.06 $2,835 - $6,122	1,508 Added 56.63%	4,171 $12,000
Q1 2022 May 16, 2022	SELL	$2.78 - $4.7 $4,089 - $6,913	-1,471 Reduced 35.58%	2,663 $9,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.9 $15,998 - $28,524	4,134 New	4,134 $17,000

Others Institutions Holding LEXX

# of Institutions

Shares Held

2.34M

Call Options Held

Put Options Held

Sabby Management, LLC Upper Saddle River, NJ

1.17M
Shares

$967,069
25.66% of portfolio
Invenomic Capital Management LP Boston, MA

501K
Shares

$416,218
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

175K
Shares

$145,066
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

134K
Shares

$110,849
0.0% of portfolio
Toronto Dominion Bank Toronto, Ontario, A6

133K
Shares

$110,493
0.0% of portfolio

View Full List

About Lexaria Bioscience Corp.

Ticker LEXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,951,000
Market Cap $4.94M
Description
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...

More about LEXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account